Objectives To evaluate the relationship between CIMT, MA, atherosclerosis extent and CV event rates in patients with established atherosclerosis.
Methods Baseline mean-CIMT and MA was assessed in 149 polyvascular atherosclerosis patients with angiographic arterial stenosis ≥50%, who underwent revascularisation procedure in ≥1 arterial territory, and in 40 control subjects without significant lesions. Results For CIMT≥1.38 mm (≥3rd quartile), the sensitivity and specificity of ≥3-territory involvement were 90.0% and 82.6%. MA≥6.85 mg/dl (≥3rd quartile), the sensitivity and specificity of ≥2-territory involvement were 54.9% and 83.3%. CV events occurred in 104 subjects. The Kaplan-Meier 2-year CV event-free survival was 93. 9% Conclusions In patients undergoing revascularisation procedure (s), CIMT has an important and independent contribution to further CV risk stratification. The mean-CIMT value ≥1.38 mm is associated with 1.8-fold increased risk of adverse CV events and the MA value ≥6.85 mg/dl is associated with nearly 1-fold increased risk of adverse CVevents.
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POLYVASCULAR ATHEROSCLEROSIS EVALUATION IN PATIENTS WITH ASSESSMENT IN CARDIOVASCULAR RISK THICKNESS AND MICROALBUMINURIA THE ROLE OF CAROTID INTIMA-MEDIA

